Top Markets
#1 Fabric Protocol Fabric Protocol +38.98%
#2 GALA GALA +37.33%
#3 Magma Finance Magma Finance +35.47%
#4 COTI COTI +31.99%
#5 Wrapped STX (Velar) Wrapped STX (Velar) +30.56%
#6 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +29.58%
#7 Tutorial Tutorial +28.70%
#8 Bitcoin Cash Bitcoin Cash +28.42%
#9 Binance-Peg ZEC Binance-Peg ZEC +26.27%
#10 OmniBridge Bridged Zcash (Solana) OmniBridge Bridged Zcash (Solana) +26.13%
Coin of the day
Fabric Protocol Fabric Protocol
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Achilles Therapeutics plc Achilles Therapeutics plc

Achilles Therapeutics plc

ACHL
Classifica tra le azioni #24575
Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused... Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused on immuno-oncology. The firm specializes in creating innovative precision T-cell therapies designed to combat a range of solid tumors. Its primary therapeutic candidates, both currently undergoing Phase I/IIa clinical trials, are CHIRON, aimed at advanced non-small cell lung cancer, and THETIS, targeting metastatic or recurrent melanoma. Beyond these, Achilles is also advancing its pipeline with treatments for head and neck squamous cell carcinoma, renal cell carcinoma, triple-negative breast cancer, and bladder cancer. Initially incorporated as Achilles TX Limited, the company officially adopted the name Achilles Therapeutics Plc in February 2021. Established in 2016, its corporate headquarters are situated in London, United Kingdom.
Prezzo delle azioni
$1.48
Ultima sincronizzazione: 2025-03-24
Capitalizzazione di mercato
$59.05M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
GB
Scambia Achilles Therapeutics plc (ACHL)

Categoria

Healthcare
Rapporto P/B per Achilles Therapeutics plc (ACHL)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Achilles Therapeutics plc, il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Achilles Therapeutics plc da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH